Drug Designing and Biomarkers

biomarker is an attribute which will be studied as an indicator of pathogenic and biological operation alongside pharmacological retort to a therapeutic involvement. They indicate either normal or diseased activity within the body. Biomarkers are specific molecules, genes, gene products, hormones, cells or enzymes.

Drug Designing is an ingenious process to seek out new medication centered on the knowledge of biological target. Drug is most ordinarily a little molecule that inhibits or activates the function of a biomolecule, which successively outcomes during a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. This sort of modelling is usually mentioned to as computer-aided drug design.

  • Drug targets
  • Ligand-based design
  • Structure-based design
  • Computer-aided drug design
  • Scoring functions

    Related Conference of Drug Designing and Biomarkers

    September 08-09, 2025

    23rd International Conference on Structural Biology

    Frankfurt, Germany
    September 29-30, 2025

    21st World Congress on Structural Biology

    Aix-en-Provence, France
    May 04-05, 2026

    7th International Conference on Drug Chemistry

    Paris, France
    September 03-04, 2026

    16th World Glycobiology Congress

    Aix-en-Provence, France

    Drug Designing and Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in